Skip to main content
. 2007 Aug 4;57(3):379–388. doi: 10.1007/s00262-007-0377-1

Table 1.

Cohorts of patients according to GM-CSF dose in CRC patients treated with anti-EpCAM MAb and cytokines in relation to treatment cycle number

Dose cohort of GM-CSF (μg/m2/day) Treatment cycle number
I (n = 50) II (n = 38) III (n = 28) IV (n = 25)
65 1 3 3 2
75 5 0 1 3
125 0 1 1 1
150 0 6 1 3
175 0 1 0 0
200 20 9 9 9
250 24 16 13 5
300 0 1 0 2
325 0 1 0 0